Gevorg Yaghjyan/LinkedIn
Apr 9, 2026, 14:46
Gevorg Yaghjyan: Advancing Research and Care for Transketolase Deficiency at Yale
Gevorg Yaghjyan, Project Leader at Parexel, shared a post on LinkedIn:
”New rare-disease research and clinical program has recently been launched at the Yale School of Medicine focusing on Transketolase (TKT) deficiency, an extremely rare genetic metabolic disorder.
The Yale Transketolase Deficiency Program was established to:
- Improve diagnosis of patients with this rare disorder
- Conduct cutting-edge research on the disease mechanism
- Develop future therapeutic strategies
- Provide multidisciplinary clinical care for patients with suspected or confirmed disease
The program is led by physicians and researchers including Andrew Wang and Anna Szekely at Yale.
It collaborates with major rare-disease networks such as:
the Undiagnosed Diseases Network
the National Organization for Rare Disorders (NORD)
to identify additional patients worldwide and accelerate research”
Stay updated with Hemostasis Today.
-
May 24, 2026, 17:13Mahtab Mashayekhi: The Evolving Role of Red Blood Cell Exchange in the Management of SCD
-
May 24, 2026, 17:12Silvina Graña: Helping Families Better Understand Hemophilia and Daily Life With Bleeding Disorders
-
May 24, 2026, 17:11Miikka Vikkula: Key Insights from the ISSVA 2026 World Congress
-
May 24, 2026, 17:10Mathieu Jackson: Proud to Be Present at This Historic Moment for the Global Bleeding Disorders Community
-
May 24, 2026, 17:09Ramina Fazeli: Highlighting the Emerging Role of Neutrophil Extracellular Traps in Ovarian Cancer
-
May 24, 2026, 16:12William Wallace: Normal B12 Levels May Still Cause Brain Damage and Cognitive Decline
-
May 24, 2026, 15:54Marc Carrier: Ottawa Race Weekend Raised Over 7,000 USD for Thrombosis Canada
-
May 24, 2026, 15:44Janak Sadhu: Building a Stroke-Free Mehsana Through Community Awareness and Healthcare Collaboration
-
May 24, 2026, 15:33Mohammed Zubair: AI-Driven Innovation in Stroke Diagnosis and Medical Imaging